✦ LIBER ✦

Blockade of the Endocannabinoid System for the Reduction of Cardiometabolic Risk Factors

✍ Scribed by Frederick F. Samaha; Carol M. Chou

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The Endocannabinoid System: Potential fo

✍ Henry N. Ginsberg; Stephen C. Woods 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 194 KB

CB1 Receptor Blockade and its Impact on

✍ A. J. Scheen 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 174 KB

Chronic monoacylglycerol lipase blockade

✍ Ramesh, Divya; Booker, Lamont; Burston, James J; Schlosburg, Joel E; Blankman, J 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 749 KB

The Medical Cost of Cardiometabolic Risk

✍ Patrick W. Sullivan; Vahram Ghushchyan; Holly R. Wyatt; James O. Hill 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 124 KB

Predicting the Prevalence of Cardiometab

✍ Christopher S. Hollenbeak; D. Eldon Spackman; Rami H. Ben-Joseph; Lynn J. Okamot 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 118 KB

Association of intraocular pressure with

✍ Chang, Y C; Lin, J-W; Wang, L C; Chen, H M; Hwang, J J; Chuang, L M 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 287 KB